The emergence of the H1N1 influenza virus earlier this year has put the world on notice for the next influenza pandemic. Participants in this press conference provide an overview of the current H1N1 situation and discuss recent advances concerning antiviral resistance, influenza-bacteria interactions and vaccines.
- Nancy Cox, Ph.D., Director, Influenza Division, U.S. Centers for Disease Control
- Jonathon McCullers, Associate Member, Associate Member, Dept. of Infectious Disease, St. Jude Children's Research Hospital
by ccondayan